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The objective of this work is to use direct Monte Carlo techniques in simulating drug delivery from compacts of com-
plex composition, taking into consideration the special features of the in vitro dissolution environment. The paper focuses
on simulating a binary system, consisting of poorly soluble drug, dispersed in a matrix of highly soluble acid excipient. At
dissolution, the acid excipient develops certain mechanisms, based on local pH modiﬁcations of the medium, which
strongly inﬂuence drug release. Our model directly accounts for such eﬀects as local interactions of the dissolving compo-
nents, development of wall roughness at the solid–liquid interface, moving concentration boundary layer and mass trans-
port by advection. Results agree with experimental data and have demonstrated that when modelling dissolution in vitro,
special attention must be paid to including the particular conditions of the dissolution environment.
 2006 Elsevier B.V. All rights reserved.
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Cellular automata1. Introduction
In vitro dissolution testing is important in designing, developing and testing new formulations [23,6]. In
order to achieve the appropriate concentrations of the desired drug in vivo (i.e., in the target organs and tis-
sues), during the desired period of time, the dissolution proﬁles in vitro need to satisfy certain criteria, gener-
ally established by the pharmacopoeias [24,6]. Thus dissolution in vitro can be regarded as the ﬁrst step toward
modelling in vivo dissolution and absorption. The dissolution rate is measured, in practice, using one of a
number of standard dissolution test methods outlined in international pharmacopoeias, such as the European
Pharmacopoeia (Ph Eur) and United States Pharmacopoeia (USP). One commonly used dissolution test appa-
ratus is the Paddle Dissolution Apparatus (see Fig. 1), known as Apparatus 2 [1].
However, there is a number of diﬃculties related to in vitro dissolution testing. Very often, the relation
between the formulation and process parameters of a pharmacological compact, and its required in vitro dis-1569-190X/$ - see front matter  2006 Elsevier B.V. All rights reserved.
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Fig. 1. Schematic representation of the USP (United States Pharmacopoeia) Paddle apparatus.
858 A. Barat et al. / Simulation Modelling Practice and Theory 14 (2006) 857–873solution proﬁle, is not entirely understood, due to the complexity of mass transport at dissolution. Complex
mass transport often results in barely tractable eﬀects, like interactions and synergies. For these reasons,
experimentation associated with the ﬁeld of drug design is very costly and time consuming. Thus, modelling
the drug release can increase the performance in the design of new products by, on the one hand, making pre-
dictions and selecting the best candidate parameters to be experimentally tested and, on the other hand, help-
ing to develop scientiﬁc understanding of the phenomena involved in the dissolution process.
Many diﬀerent modelling approaches to drug dissolution have been taken throughout the last decades, with
mathematical modelling prevailing [23,22,18,4]. Other, less traditional alternative methods, like stochastic
approaches [2], direct Monte Carlo (MC) methods [9,8,25,13,15,14], artiﬁcial neural networks (ANN) and
genetic algorithms (GA) [24], have also recently been considered. These methods, used in parallel with the tra-
ditional ones, bring complementary advantages, such as the possibility of investigating the microscopic aspects
of the problem in the case of MC methods, and optimisation schemes in the case of ANN and GA.
Previous research has indicated that direct MC could be a valuable tool in the ﬁeld of modelling the dis-
solution of drug delivery systems characterised by complex internal structure [9,25,15].
Monte Carlo (MC) methods are used for solving various kinds of computational problems using random
pseudo-random numbers. MC is extremely important in computational physics and related applied ﬁelds,
because phenomena, which are diﬃcult to quantify directly, can be treated as distributions of random num-
bers. Monte Carlo simulations have been considered for solving diﬀerent problems associated with multiple-
particle systems. Very often in these cases, Monte Carlo techniques have been applied in the framework of
Cellular Automata, as shown in Part 1. Previous to being used to simulate systems such as those involving
drug dissolution and delivery, the combination of direct Monte Carlo techniques and Cellular Automata have
proved useful in the study to many other kinds of systems exhibiting complex behaviour [3,16].
In this paper, we explore the possibilities of MCmodelling, for investigating the in vitro dissolution of a par-
ticular class of compacts (used as model drug delivery systems in Healy and Corrigan [11]). The behaviour char-
acteristic for these compacts in reactive media seems to be diﬃcult to predict. Besides diﬀusion investigation,
the model is designed to capture the particular features of the in vitro environment intrinsic to a dissolution
paddle apparatus. The dissolution proﬁles generated by the Monte Carlo approach were found to be in accord
with experimental observations on the dissolution of ibuprofen/acid excipient model drug delivery systems.
The following two sections are dedicated to the presentation of the problem and the solutions for solving
diﬀerent aspects of it, proposed in the literature. The last section presents our MC model solution.
2. Multicomponent soluble compacts and in vitro environment
2.1. Binary compacts
In the area of modelling dissolution of drug delivery systems, multicomponent soluble systems have not
received enough attention, despite the fact that solid dosage forms invariably contain multiple soluble compo-
nents [20]. Several theoretical approaches to describing binary systems are due to Ramtoola and Corrigan [20]
and references therein. In the case of non-ionizable binary systems, where the components have diﬀerent solu-
bilities (Csx and Csy ) and diﬀerent diﬀusion coeﬃcients (Dx and Dy), at the start of the diﬀusion process, the two
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ponents will generally remain at the solid–liquid interface. The other component will have to dissolve through
the porous system formed inside the less soluble component. Only at the critical mixture ratio, deﬁned by
Nx
Ny
¼ DxCsx
DyCsy
ð1Þ
will there be no porous layer formed at the surface and both components will dissolve at a rate equal to that of
the pure component. In each case, Nx and Ny are the original amounts of components x and y. In the general
case, the dissolution rates of the components are calculated according to Fick’s ﬁrst law [5]. When a steady
state is reached, the limiting dissolution rate of the component which remains at the surface is given by
Gx ¼ Dxh Csx ð2Þ
while the dissolution rate of the receding component y is given by
Gy ¼
DyCsy
hþ se
 ðs1  s2Þ ð3Þ
where h is the thickness of the diﬀusion ﬁlm, s is the tortuosity, referring to the complexity of the system of
channels which forms in 3D, e is the porosity (often unknown though) and (s1  s2) is the thickness of the
porous layer formed at the solid–liquid interface. In the case where the components are ionizable the situation
is more complex [20]. In experiments on the dissolution of benzoic and salicylic acids in buﬀered media, the
authors found that the dissolution rates, particularly for benzoic acid at intermediate weight fractions, were
lower than theoretical rates and explained these in terms of surface pH eﬀects.
Subsequently, Healy and Corrigan [11,12] have conducted experimental and theoretical studies on the dis-
solution of soluble ibuprofen/acidic excipient compressed mixtures in reactive media, using model compacts.
These were obtained by ﬁrst grinding the two components in powders, mixing the products, and ﬁnally com-
pressing them. On dissolution in reactive media, the compacts exhibit complex behaviour, in spite of their bin-
ary composition. The authors have presented a modiﬁed model for dissolution of binary systems of ibuprofen
and various acid excipients. The predicted dissolution rates for the excipients tend to be higher than those
obtained experimentally in the case of more soluble acids.
2.2. Introduction to the in vitro dissolution medium
2.2.1. Dissolution apparatuses
As mentioned before, one of the speciﬁc interests of this paper is to take into consideration the in vitro envi-
ronment used for dissolution testing, because the settings of the dissolution apparatuses are known to aﬀect
the process of compact dissolution. In Healy and Corrigan, 1992 [11], the in vitro environment consisted of a
water-jacketed ﬂat-bottomed dissolution apparatus [10], and in Healy and Corrigan, 1996 [12], a more stan-
dard dissolution apparatus: USP type 2 has been used (see Fig. 1).
A standard dissolution apparatus consists of a container, ﬁlled with the dissolution medium, with the com-
pact situated at the bottom of the apparatus (see Fig. 1). The dimensions of the apparatus are such that we can
make the assumption that the solvent inside has sink or close-to-sink properties (i.e., the system behaves as if
the tablet dissolves in an inﬁnite solvent).1
A paddle is used to stir the buﬀer solution at a constant rate. The stream created produces a velocity bound-
ary layer around the compact. There are two mechanisms of mass transport in the system: diﬀusion and advec-
tion,2 the latter due to the component of the stream velocity oriented along the surface of the compact. This
component is responsible for carrying away quantities of matter proportional to its strength. One of the tar-
gets of the present work was to build into our Monte Carlo model both mechanisms of transport: both dif-
fusion and advection.1 This means that far away from the dissolving compact, the concentration of solute in the solvent can be approximated by zero.
2 The term ‘‘advection’’ refers to the transport of material from one region to another.
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The hydrodynamic conditions of the in vitro environment are such that the velocity boundary layer at the
top of a cylindrical compact is very diﬃcult to describe. Crane et al. [7,6] investigated the velocity boundary
layer, as well as the concentration boundary layer formed around the curved surface of a cylindrical compact
in the USP apparatus, in order to better understand the concentration proﬁles which form at the solid–liquid
interface as dissolution takes place.
In this study, the component of the ﬂuid ﬂow, parallel to the curved surface of the cylinder, is examined.
Far away from the compact, the ﬂuid ﬂows at its maximum speed: ~U 0, but approaching the solid–liquid inter-
face, the velocity decreases to zero at the surface of the solid, where the ‘‘non-slip’’ condition holds. Hence, the
term of velocity boundary layer refers to the small region of space close to the solid immersed into the ﬂowing
liquid, where the ﬂow velocity varies from zero to it’s maximum ~U 0 (see Fig. 2(a)).
As the solid dissolves, a concentration proﬁle is established at the solid–liquid interface. Since the ratio of
the diﬀusivity to the kinematic viscosity of the ﬂuid (i.e., of the buﬀer solution), Dm , is very much less than unity,
the diﬀusion boundary layer thickness dc is smaller than the velocity boundary layer thickness d [7]. For the
immediate solid–liquid interface, in contrast to the velocity proﬁle, the concentration is at saturation, decreas-
ing to zero with the distance from the surface (see Fig. 2(b)). Thus, by the term concentration boundary layer,
we mean the region of solution in the solid–liquid interface, where the concentration of solute in the solvent is
greater than zero. The thicknesses of velocity/concentration boundary layers vary with the distance from the
leading edge of the compact (Fig. 2).2.2.3. Mathematics for boundary layers
The velocity boundary layer thickness for a ﬂat plate in an axial ﬂow is given by the solution of Blasius
equation [19,21]:
d ¼ 3:4
ﬃﬃﬃﬃﬃﬃ
xm
U 0
r
ð4Þ
where x is the distance from the leading edge of the compact (Fig. 2) and m and U0 are deﬁned as previously.Fig. 2. (a) The velocity boundary layer of a non-dissolving solid immersed in a ﬂowing liquid. d is the thickness of the boundary layer, the
exterior curve indicates the points in the space where the velocity is at its maximum. (b) Velocity and concentration boundary layers for a
dissolving solid. dc is the thickness of the concentration boundary layer. The curve situated closer to the compact surface indicates the
points in space where concentration of solute in solvent reaches low, close to zero, values.
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d
dc
¼ Sc13 ð5Þ
where Sc is the Schmidt number, deﬁned as
Sc ¼ m
D
ð6Þ
Once the thickness of the concentration boundary layer has been computed, it is possible to compute the
value C* of the maximum concentration at each point (y,x) (Fig. 2), within the boundary layer. One way to
compute the concentration in the boundary layer is to use the Pohlhausen solution, which approximates the
variation of concentration by either a polynomial, or, in the case of Crane et al. [6], by a sinusoid:
C
Csatur
¼ 1 sin py
2dc
 
ð7Þ
Here, Csatur is the saturation concentration of a given component, C* is the concentration at a given point y
within the concentration boundary layer and dc is the thickness of the boundary layer at a given height of the
cylindrical compact.
From simpliﬁcation considerations, the problem of in vitro radial dissolution was investigated in [6,7] for
simple layered binary systems (with three to ﬁve alternate layers, as in Fig. 3). The investigation used numer-
ical methods in combination with a Pohlhausen proﬁle (see Eq. (7)), to model the concentration boundary
layer formed around the dissolving cylindrical device in the USP apparatus.
Numerical results, depicting the concentration proﬁle within the boundary layer during a very short period
of time, from ﬁnite element techniques, together with those from a semi-analytical Pohlhausen type approx-
imation to the concentration boundary layer, have shown good agreement with experimental data. These stud-
ies have demonstrated that the in vitro conditions have an important impact on the way in which a compact
dissolves. However, the boundary layer problem for dissolving matrix compacts has not been considered yet.
It seems that the matrix compacts exhibit physics which are less tractable by numerical methods.
2.3. Experimental situation
We use the data obtained by Healy and Corrigan [11] for the dissolution of ibuprofen and a wide range of
acid excipients from mixed disks in reactive media (phosphate buﬀer), as reference.
The compacts used in the experimentation were cylinders, obtained by compressing 250 mg of powder, hav-
ing a composition of drug and excipient on a weight-for-weight basis. Previous processing by grinding and
sieving of the components permits control of particle size of both drug and excipient powders. The drug
and the excipient have dramatically diﬀerent solubilities and slightly diﬀerent diﬀusivities, while the acidic
excipient has an eﬀect on the solubility of ibuprofen at dissolution. The compact dissolves according to the
following mechanism: at the dissolution of the acid excipient, the pH of the buﬀer decreases and this has aFig. 3. Layered compact versus matrix compact.
Table 1
Solubilities of the acid excipients, from [10]
Type of acid excipient Solubility (mg/ml)
Adipic 44.4
Succinic 120.4
Maleic 694
Tartaric 764.5
Citric 883.6
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Fig. 4. Experimental results. (a) Dissolution proﬁles of the acid excipients from 40:60 ibuprofen/acid excipient compressed discs. (b)
Dissolution proﬁles of ibuprofen from 40:60 ibuprofen/acid excipient compressed discs. The vertical axis represents the mass fraction of
released drug, i.e., the ibuprofen. Based on published data [11].
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was a water-jacketed ﬂat-bottomed 450 ml cylindrical glass vessel. Two hundred and ﬁfty millilitres of medium
were used. The medium was stirred with a three-blade stirrer immersed to a depth of 2.5 cm [10].
As an example, Fig. 4 represents the dissolution of diﬀerent cylindrical binary matrix systems: all of them
contain ibuprofen (solubility = 6.3 mg/ml [10]) and an acid excipient of much higher solubility (see Table 1).
The left part of Fig. 4(a) represents the dissolution proﬁles for four diﬀerent acid excipients. The right part of
Fig. 4(b) shows the dissolution proﬁles for the drug, which is ibuprofen in all cases. It can be observed from
Fig. 4 that the more soluble the excipient, the more it suppresses the solubility, and therefore the release of
ibuprofen.
3. Modelling
3.1. Main characteristics of the model
In this investigation, we simulated the dissolution of the binary soluble system presented in the previous
sections, using a 2D lattice and a Monte Carlo algorithm, as described below. The model speciﬁcally takes
into consideration both the diﬀusion and the advection. The algorithm is implemented in C++ and the library
OpenGL has been used for the visualisation.
We represent the two solid species by particles with diﬀerent properties. These particles can be moved on
the sites of the lattice according to rules. In this particular case, we make the assumption that one species dis-
solves independently and is referred to as the excipient in the following, while the dissolution of the other spe-
cies strongly depends on that of the former. We refer to this last species as the drug, to match the terminology
of the experimental system we consider. The solvent is represented by empty sites. The state of a site (i, j), w(i,j)
is deﬁned by the quantity and type of the particles with which it is ﬁlled, i.e., the concentrations CD(i, j) and
CE(i,j) of drug and excipient particles, respectively. The state of any site can evolve in time according to a func-
tion, which depends on the concentrations at the site itself and those in the local neighbourhood (Fig. 12). The
process of diﬀusion is simply simulated by the tendency of particles to move to adjacent sites according to
speciﬁed rules. Fig. 5 illustrates the possible states in the model and their schematic behaviour.
Fig. 5. 2D Model for a dissolving binary system. (a) Schematic representation of 2D model. The real dimensions are not respected in the
picture. (b) Simpliﬁed model of dissolution of a drug-excipient system. The grid represents a cylindrical tablet in longitudinal cut. The
shots show the beneﬁts of this kind of model for simulating cases where pores are formed inside a compact by the quick dissolution of one
of the components. The second component has to dissolve through these pores and this process is diﬀerent from dissolution at the surface.
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ME(t), at each time step.
3.2. The initialisation
The spatial conﬁguration of the DDS is generated as follows:
• For each site of the lattice, which has to be occupied by ‘‘matter’’ in solid state, a random number uni-
formly distributed between 0 and 1 is generated.
• If this number is smaller than or equal to the proportion of drug, this site is considered as drug. It’s state is
assigned w(i,j)(t) = jD, and the site is ﬁlled with a number nD of drug particles.
• Otherwise, the site is ﬁlled with nE excipient particles and w(i,j)(t) = jE.
• In order to simulate the phenomena at the solid–liquid interface, the sites around the solid are assigned the
liquid state: solution. We distinguish two types of solution states: (i) sites which are situated in the immediate
proximity to the solid–liquid interface, forming the boundary layer with thickness dc (see Section 2.2):
w(i,j)(t) = j, and (ii) sites far enough from the dissolving compact, behaving as a sink3: w(i,j)(t) = js (see
Fig. 5).3 The main diﬀerence between the boundary layer solution sites and the sink solution sites is that the ﬁrst can receive and accommodate
diﬀusing drug and excipient particles, whereas the second have the concentration of the diﬀusing species set to zero. This artifact comes
from the assumption that the concentrations in the stirred liquid are so much smaller than the concentrations in the boundary layer, that
these are approximated by zero: C(i,j) = 0 when j = dc. When, in later stages, particles reach a sink solution site, they will be considered
completely dissolved, thus they will be discarded from the system and their quantities—added to MD(t) and ME(t).
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uted the following states: leaking drug and leaking excipient (w(i,j)(t) = j+ and w(i,j)(t) = jx). From this
instant, the particles from these sites will be allowed to move. The content in particles of leaking sites
can only decrease.
3.3. Modelling the diﬀusion
Diﬀusion refers to the process by which molecules of diﬀerent species intermingle as a result of their kinetic
energy. In the model we represent the two solid species by particles. Since the components in the compact have
highly diﬀerent solubilities, they are expected to dissolve at diﬀerent rates. For this reason, we allow for more
than one particle to move to an adjacent site. The solubility of a given species is modelled by allowing not
more than a ﬁxed number of particles, S = CMAX, on the sites considered as ﬁlled with solvent. The maximum
allowed concentrations in the solvent, CMAXDrug and CMAXExcipient , are proportional to the real solubilities. This
means that the ratio
CMAXDrug
CMAXExcipient
equals to the solubility ratio SDSE between the drug and the excipient. In addition,
the local solubility of a component depends on the local concentrations [11].
Only the sites in the states w(i,j)(t) = j, w(i,j)(t) = j+ and w(i,j)(t) = jx can diﬀuse. If the site (i,j) is in one of
the above states, the possibility of diﬀusion is considered by ﬁrst looking at the kind of particles about to dif-
fuse: dependent (drug) or independent (excipient) particles.
The decision to permit a batch of particles to diﬀuse is accepted or rejected by:
• Consulting a gradient-dependent probability, pE in the case of the excipient (Eq. (8)). In the following, (i, j)
symbolises the current site and (i*, j*)—the adjacent site to which the possibility of diﬀusion is considered.
pE ¼
CEði;jÞ  CEði;jÞ
CEði;jÞ
ð8Þ
• Consulting a probability, dependent on the excipient concentration in the neighbourhood, pD0
(pD0 ¼ f ð
P
CEði;jÞÞ) and a further, gradient-dependent probability, pD1 (Eq. (9)) in the case of the drug
particles about to diﬀuse.
pD1 ¼
CDði;jÞ  CDði;jÞ
CDði;jÞ
ð9Þ
• The diﬀusion operation itself is performed by calculating the number of particles of excipient, fE, and those
of drug, fD, which will move to each of the adjacent sites. The number of excipient particles which hop from
the site (i, j) to the site (i*, j*) are given by:
fE ¼ pE  X E ð10Þ
where XE is a variable uniformly distributed between one particle and the maximum number of particles
allowed on the site (i*, j*). The quantity of the particles on a site is limited by the species solubility CMAX,
therefore:
X E ¼ U 1;CMAXE  Cði;jÞE
  ð11Þ
• A normal distribution can be used as well to calculate XE.
In order to perform a synchronous updating of the diﬀusion operation, we compute for all the cells on the
lattice the incoming and outgoing quantities, and only then update the actual concentrations and increment
the Monte Carlo time step. After the update, all the particles which diﬀuse to sites in a state of sink solution
w(i,j)(t) = js, are considered to be completely dissolved and are discarded from the system. The values of
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system.
3.4. Modelling the advection
As mentioned, advection plays an important role in mass transport in the in vitro environment of the appa-
ratuses used for dissolution testing. The ﬂow created in these is very complex [7,6,17]. In this model we make
the assumption that there is always a stream component which is oriented parallel to the surface of the com-
pact, exposed to the dissolution medium.
If we do simulations in which the size of the site is much smaller then the thickness of the diﬀusion
boundary layer, the advection operation can be performed using the Pohlhausen concentration proﬁle (see
Section 2.2) in a discretized form, adapted for our lattice model: (CEði;jÞ, w(i,j)(t) = j). We make the assump-
tion that a velocity/concentration boundary layer is established at the liquid/solid interface. At the surface
the velocity is zero and thus the concentrations of all the diﬀusing species are at saturation. Therefore, in
the immediate proximity to the solid surface, there are only diﬀusion-based phenomena. As we move away
from the surface, the velocity increases from zero to its maximum ~U 0. In the same time, the concentration
decreases, because the ﬂow is responsible for carrying away quantities of matter proportional to the velocity
of the stream.
In order to simulate the advection process, we consider every solution site within the boundary layer and
the number of particles of drug and excipient aD(i,j) and aE(i,j) which will be carried away from it by the stream,
to symbolise the mass transport property. The quantities aD(i,j) and aE(i,j) are computed so that, after they will
have been discarded from the system, a concentration Pohlhausen proﬁle (Eq. (7)) in a discretized form
appears in the boundary layer region.
After an advection step is performed, there are sites from the boundary layer, in solution state, which have
the outgoing quantities of particles, aD(i,j) and aE(i,j), diﬀerent from zero. The corresponding update operation
consists of a sweep of the lattice which ﬁnds and discards these particles from the system, symbolising the mass
transport due to advection. These values are added respectively toMD(t) and ME(t), while aD(i,j) and aE(i,j) are
re-set to zero.
As the tablet dissolves, the boundary layer recedes in the space.
In the case in which the size of a site is of the same order of magnitude as the thickness of the diﬀusion
boundary layer, the advection mass transfer can be performed by inverse Monte Carlo simulations. We con-
sider that diﬀusion in the pores and diﬀusion at the surface of the solid does not happen in the same way. At
the surface, larger XE than in Eq. (11) (see previous section) are allowed to diﬀuse to adjacent sites. A normal
distribution can be used in this case: XE = N(l,r), where l is the mean and r is the standard deviation of the
distribution. In order to ﬁnd out l and r, it is possible to
• Sample values for l and r: li and ri-from, for example, uniform distributions.
• Use these values to perform a simulation and generate a dissolution proﬁle.
• Compare the dissolution proﬁle obtained to the real data.
• Accept li and ri if the results of the simulations are satisfactory.
• Reject li and ri in case of unsatisfactory results, re-sample other values, li+1 and ri+1, and repeat the
mentioned steps.
3.5. Updating
Before beginning any mass transport operation, the following update is performed:
* If w(i,j)(t  1) = jD and this site has any solution j in the neighbourhood then
w(i,j)(t) = j+.
* If w(i,j)(t  1) = jE and this site has any solution j in the neighbourhood, then
w(i,j)(t) = jx.
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all the connected to it cluster of pores turns into solution.
If the concentration of a leaking site decreases under the solubility (CMAXD or CMAXE), its state is updated to
the solution state. This implies that the particles at the site are completely dissolved and that the site can begin
to receive new particles:
* If
wði;jÞðt  1Þ ¼ jþ
CDði;jÞ 6 CMAX D

then w(i,j)(t) = j
* If
wði;jÞðt  1Þ ¼ jx
CEði;jÞ 6 CMAX E

then w(i,j)(t) = j
After the updating phase, the diﬀusion can begin.
4. Results and discussion
A MC time step, corresponding to time t, is a sequence of applying the operations of diﬀusion, advection
and updating to all the sites from the lattice. The system is left to evolve during many MC iterations, incre-
menting the time value after each iteration. Samples of MD(t) and ME(t) are taken periodically, in order to
plot their proﬁles at the end of the simulation.
We average simulation results on a certain number (25 in the following) of initial conﬁgurations of the device,
because the spatial packing of the two components in the compact has a slight eﬀect on the dissolution results.
In this section, we analyse the capacity of the model described above to predict correct eﬀects of the design
parameters, like initial drug loading, initial porosity, form of the compact, etc., on the dissolution rates.
Besides its purpose of conserving the behaviour encountered in the real problem (by the microscopic content
of the rules speciﬁed), a computer solution is prone to develop and exhibit its own special eﬀects. These may
interfere with the relevant trends. We desire to investigate the extent to which the purely numerical phenomena
may aﬀect the results of the simulations.
4.1. The eﬀect of the acid excipient solubility
The suppression eﬀect of the acid excipient is indirectly modelled by deﬁning rules for dramatically decreas-
ing the diﬀusing probabilities of the drug in the presence of local high concentrations of excipient. We have
carried out simulations with binary systems where the properties of the dependent species (drug) have been
kept the same for all the experiments with diﬀerent solubility of the independent and more soluble species
(excipient). The excipient received a wide range of solubilities noted SE.
Fig. 6 compares the behaviour of the system for two diﬀerent excipients E1 and E2, one with a high solu-
bility and the other with lower solubility SE1 > SE2 . The properties of the dependent component, the drug, are
kept constant during the two simulations and SE1 > SD, SE2 > SD. Fig. 6(a) and (c) shows the concentration
proﬁles for, respectively, E1 and E2. In both cases irregular dissolution fronts are developed, but the extent of
their roughness is obviously a function of the solubility of the excipient. The excipient inﬂuences the dissolu-
tion of the dependent species by ﬁlling the free space with its particles and consequently decreasing the local
solubility of the drug. The higher the solubility of the excipient, the higher the capacity of a solution site to
accommodate excipient particles.
For the case of E1, it can be noticed that the excipient has strongly receded from the surface (Fig. 6(a)), and
has created a porous layer, through which the poorly soluble drug dissolves only in the region where the excip-
ient concentrations are very low (Fig. 6(b)). The drug dissolves through the pores created by the dissolution of
E1. For E2 very diﬀerent behaviour is exhibited. The porous layer is much thinner than in the previous case
and the drug boundary has receded inward to a greater extent. This type of behaviour of binary drug delivery
systems has been observed and described by [20].
We have plotted the fraction of the dissolved drug and excipient against the time, comparing the dissolution
proﬁles of drug and excipient with those obtained in the experiments. The results reproduce very well the
Fig. 6. Colours code: green—solid excipient, blue—solid drug, yellow—pores, white—solution in the boundary layer, clear blue—sink
solution, shade of red in (a) and (c)—the concentration of excipient in the boundary layer solution, shade of red in (b) and (d)—the
concentration of drug in the boundary layer solution. All the ﬁgures show the state of a 130/80 sites compact after 4000 generations. (a)
and (b) System where the excipient has a relatively high solubility: SE = 280. (c) and (d) System where the excipient is less soluble: SE = 44.
(For interpretation of the references in colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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[11].
Fig. 7 shows the drug and the excipient proﬁles for diﬀerent solubilities and for two diﬀerent drug loadings.
The porosity of the matrix is kept constant. Every dissolution curve is obtained by averaging the results of aExcipient profile. c=0.4, p=0.15
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Fig. 7. The eﬀect of the solubility of the independent species on the dissolution of the dependent species.
868 A. Barat et al. / Simulation Modelling Practice and Theory 14 (2006) 857–873particular number of simulations (25) characterised by the same initial parameters but with diﬀerent initial
conﬁgurations of the compact (the two species are randomly distributed in the compact for each simulation).
The plots show that as the solubility of the excipient increases, the dissolution of the drug is more and more
suppressed. As in experiment, a positive curvature for the drug and a negative curvature for the excipient are
obtained.
With highly-soluble excipients, the dissolution of the drug is very slow in the beginning, and when almost
all the excipient is dissolved, the drug changes its dissolution rate, as can be seen for some of the proﬁles in
Fig. 7(c). In Fig. 7(c), the triangle diamonds proﬁle corresponds to the micro-environment represented in
Fig. 6(c) and the rhombus diamonds proﬁle shows the case of E2 (Fig. 6(d)).
We note that suppression of the advection step from the model leads to simulation results for the drug pro-
ﬁles which do not accord with experiment, hence environment-related features are important.
4.2. Loading eﬀect
If we think of what eﬀect the drug loading would produce in the beginning stages of the simulation, it is
evident that the more drug the matrix contains, the less excipient is present, hence, the higher the dissolution
rates for the drug. Fig. 8 conﬁrms this idea and shows more explicitly the eﬀect of the initial loading of drug on
the dissolution proﬁle of the components. The same trend is observed in the experimental data: the greater the
drug loading, the greater the fraction of the total drug mass released.
However if we produce simulations with an ‘‘excipient’’ of a lower solubility, like SE ¼ CMAXE ¼ 44, the
opposite eﬀect of the loading is observed (Fig. 9). For 50% of drug loading, smaller fraction of total drug mass
is released than in the case of 40% of drug.
This happens because the concentrations of excipient are not high enough to inﬂuence the drug dissolution
proﬁle. A matrix with lower initial drug loading contains a higher excipient loading. At its dissolution, the
excipient creates a certain level of wall roughness, increasing the dissolution area for the drug and thus
enhancing the drug dissolution, which is not suppressed by the relatively low excipient concentrations.
When we have performed quantitative simulations (see Section 4.5), directly comparable to the experimen-
tal proﬁles, this inversion-eﬀect appeared in the cases when running the model for mixtures of ibuprofen with
adipic acid and, respectively, succinic acid (see Table 1), while the inversion does not appear in the experimen-
tal results. Why? Because eﬀectively, the model generates too low excipient concentrations for the case of 50%
of drug loading. The cause of this may be the modelling a 3D problem in 2D, as discussed in Section 4.5). We
have also found, when calibrating quantitative models with experimental data from dissolution of ibuprofen-
only compacts, that the operation simulating advection, as set for generating the results from Fig. 9, is notS=490
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Fig. 8. Loading eﬀect for excipients with high solubility.
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Fig. 9. Loading eﬀect for excipients with relatively low solubility. (a) Dissolution proﬁles for the drug. (b) Dissolution proﬁles for the
excipient.
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advection, the inversion eﬀect has disappeared and agreement with the experimental data has been obtained.
Adipic acid is the acid with the lowest solubility (we can compare solubilities because the pKa values of all
acids is very close), for which experimental data are available. The quantitative advection-corrected model
suggests that the inversion eﬀect reappears and increases for lower values of the excipient’s solubility. Would
this be conﬁrmed in the reality if the corresponding components were available for experimentations?
4.3. The eﬀect of the initial porosity
Fig. 10 presents the simulation results for diﬀerent porosities for dissolution of compacts containing very
soluble excipients. The porosity value represents the fraction of sites belonging to the compact, which are free
of particles. For the excipient, a higher porosity value enhances its dissolution rate. This eﬀect grows stronger
with increase in the excipient solubility (Fig. 10(b) and (d)). In Fig. 10(d) the porosity factor disperses the dis-
solution proﬁles much more than in Fig. 10(b). On the other hand, the drug dissolution is suppressed moreS=280, c=0.5
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Fig. 10. Porosity eﬀect for excipients with high solubility.
870 A. Barat et al. / Simulation Modelling Practice and Theory 14 (2006) 857–873strongly at a higher porosity at the start of the dissolution phase. This is due to the suppression eﬀect of the
excipient, which dissolves well at high porosities.
Fig. 11 shows the eﬀects of the porosity on a system where the excipient is less soluble than in the previous
case. The trends for the dissolution proﬁles for the excipient are the same, but less evident, as the proﬁles are
not very dispersed. However, the eﬀects of the factor porosity for the drug diﬀer from the previous case. Here,
the higher the porosity, the higher the dissolution rate of the drug. This happens because, in this case, the drug
exhibits a more independent behaviour. This means that, for this system, there is a solubility level of the excip-
ient, for which its inﬂuence on the drug’s dissolution is completely canceled or inverted. As explained for the
loading eﬀect, more experiments are necessary to completely verify whether the eﬀects mentioned are totally
model related, or not.
4.4. Neighbourhood eﬀect
We ﬁnd that diﬀerent versions of the model are more or less adapted to simulating one or another case of
the dissolution problem. Two diﬀerent types of neighbourhoods were considered (Fig. 12(a)), and we have
found the Moore neighbourhood to be the most appropriate for our problem, because it permits for additional
directions for the particle movement in the 2D space, and this is evidently closer to the reality. Von Neumann’s
neighbourhood provides good results for compacts containing more than 50% of excipient. When the quantity
of the excipient in the tablet decreases, however, models using the Von Neumann neighbourhood, although
showing quite good trends for the drug dissolution, strongly underestimate the quantities of dissolved excip-
ient in the buﬀer solution, see Fig. 12(b). This is a model-related eﬀect, and the stated under-estimations are
due to the fact that sometimes the slowly dissolving drug sites completely block the excipient.Fig. 12. (a) Von Neumann neighbourhood. (b) Moore neighbourhood. (c) Dissolution proﬁles of adipic acid from 40:60 mixed matrices.
Continuous curve: experimental. Dots: simulations. Here the quantitative model described in the next section has been used.
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less ‘‘trapped excipient’’ eﬀects. The results presented in all the previous sections are obtained using the Moore
Neighbourhood.
4.5. Quantitative simulations
The objective of the last part of the modelling was to pass from qualitative to quantitative simulations. As
this paper is dedicated to the presentation of the problem and to the structure of the model, the work involved
in the quantitative simulations is presented here just brieﬂy. Mainly, quantifying the models consisted in:
• mapping the experimental binary system into 2D binary lattices, according to the mean size of the powder
particles of drug and excipient,
• computing the input parameters, such as number of particles per site, solubilities, the distribution of the
number of excipient particles allowed to transfer to adjacent places, time of dissolution, time interval of
sampling the quantities of interest, etc., according to the physical properties of the two components, i.e.,
diﬀusion coeﬃcients, densities ratios,
• calibrating the parameters, related to the advection process by inverse evaluation (sampling, comparing to
the experimental data, re-sampling).
• establishing the way diﬀerent acid excipients suppress the dissolution of ibuprofen.
Fig. 13 shows that the level of agreement achieved is quite good. The practical interest of a quantitative
model is obvious. It made possible evaluating quantitatively parameters related to the porosity of the matrices.
Part 1 presents more quantitative results.
Fig. 14 shows a typical formulation for which the model is able to predict only the general trend and not
very close values, like the ones in Fig. 13. This happens for the cases where the drug loading is rather high.
Two dimensions are not enough to model such conﬁgurations, because in the cases of 50% or more than
50% drug in 2D, only few channels form and they are probably not enough for the excipient to evacuate. Pres-
ently, we work on 3D models, which are expected to solve this kind of problem. Developing 3D models is
interesting also because they will be able to provide values for the tortuosity. Expression (3) can then be used
to calculate the dissolution rates. These dissolution rates can then be compared to the dissolution rates
provided directly by diﬀerent models and the experimental dissolution rates.Ibuprofen/Succinic acid. 40:60
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Fig. 13. Simulated versus experimental. Continuous lines with ﬁlled dots: dissolution proﬁles of ibuprofen and excipient from ibuprofen/
acid excipient compressed discs. Empty dots: quantitative simulated results corresponding to the experimental situations. Round dots:
ibuprofen. Square diamonds: acid excipient. The titles show what are the two components in each experiment and the weight ratio in
which they are used.
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Fig. 14. Simulated versus experimental. Continuous lines with ﬁlled dots: dissolution proﬁles of ibuprofen and excipient from ibuprofen/
acid excipient compressed discs. Empty dots: quantitative simulated results corresponding to the experimental situations. Round dots:
ibuprofen. Square diamonds: maleic acid.
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With our simple Monte Carlo model, direct consideration is taken of aspects such as time-dependent poros-
ity and thickness of porous layer, dissolution through pores, eﬀects of particle size and distribution, concen-
tration dependent solubilities, receding solid–liquid interface, dissolution over long periods of time and
advection due to the in vitro environment. Thus, essential features, necessary to reproduce the complexity
observed in the real world problem of in vitro drug dissolution, are captured. We note that suppression of
the advection step from the model leads to the fact that simulation results for the drug proﬁles do not agree
with experiment, hence environment-related features are important.
The model can also easily be modiﬁed to simulate multicomponent compacts; for example, it can be used to
see what happens if a mixture of ibuprofen/acid excipient is compressed in an inert non-soluble matrix of eth-
ylcellulose (a material used in the present day in the manufacturing of controlled release systems). In this case,
it is important to examine the percolation phenomena and the MC model has the advantage of permitting
such type of investigations.
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